BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19568270)

  • 1. An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.
    Ferrero GB; Howald C; Micale L; Biamino E; Augello B; Fusco C; Turturo MG; Forzano S; Reymond A; Merla G
    Eur J Hum Genet; 2010 Jan; 18(1):33-8. PubMed ID: 19568270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1.3-mb 7q11.23 atypical deletion identified in a cohort of patients with williams-beuren syndrome.
    Delgado LM; Gutierrez M; Augello B; Fusco C; Micale L; Merla G; Pastene EA
    Mol Syndromol; 2013 Mar; 4(3):143-7. PubMed ID: 23653586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.
    Antonell A; Del Campo M; Magano LF; Kaufmann L; de la Iglesia JM; Gallastegui F; Flores R; Schweigmann U; Fauth C; Kotzot D; Pérez-Jurado LA
    J Med Genet; 2010 May; 47(5):312-20. PubMed ID: 19897463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical 7q11.23 deletions excluding ELN gene result in Williams-Beuren syndrome craniofacial features and neurocognitive profile.
    Alesi V; Loddo S; Orlando V; Genovese S; Di Tommaso S; Liambo MT; Pompili D; Ferretti D; Calacci C; Catino G; Falasca R; Dentici ML; Novelli A; Digilio MC; Dallapiccola B
    Am J Med Genet A; 2021 Jan; 185(1):242-249. PubMed ID: 33098373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.
    Vandeweyer G; Van der Aa N; Reyniers E; Kooy RF
    Am J Hum Genet; 2012 Jun; 90(6):1071-8. PubMed ID: 22608712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits.
    Fusco C; Micale L; Augello B; Teresa Pellico M; Menghini D; Alfieri P; Cristina Digilio M; Mandriani B; Carella M; Palumbo O; Vicari S; Merla G
    Eur J Hum Genet; 2014 Jan; 22(1):64-70. PubMed ID: 23756441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual combination of an atypical maternally inherited novel 0.3 Mb deletion in Williams-Beuren region and a de novo 22q11.21 microduplication in an infant with supravalvular aortic stenosis.
    Evangelidou P; Kousoulidou L; Salameh N; Alexandrou A; Papaevripidou I; Alexandrou IM; Ketoni A; Ioannidou C; Christophidou-Anastasiadou V; Tanteles GA; Sismani C
    Eur J Med Genet; 2020 Dec; 63(12):104084. PubMed ID: 33045407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare genomic rearrangement in a boy with Williams-Beuren syndrome associated to XYY syndrome and intriguing behavior.
    Dutra RL; Piazzon FB; Zanardo ÉA; Costa TV; Montenegro MM; Novo-Filho GM; Dias AT; Nascimento AM; Kim CA; Kulikowski LD
    Am J Med Genet A; 2015 Dec; 167A(12):3197-203. PubMed ID: 26420477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
    Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
    Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
    Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
    Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and phenotypic characterization of atypical Williams-Beuren syndrome.
    Euteneuer J; Carvalho CM; Kulkarni S; Vineyard M; Grady RM; Lupski JR; Shinawi M
    Clin Genet; 2014 Nov; 86(5):487-91. PubMed ID: 24246242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Williams-Beuren syndrome in Mexican patients confirmed by FISH and assessed by aCGH.
    Ramírez-Velazco A; Aguayo-Orozco TA; Figuera L; Rivera H; Jave-Suárez L; Aguilar-Lemarroy A; Torres-Reyes LA; Córdova-Fletes C; Barros-Núñez P; Delgadillo-Pérez S; Dávalos-Rodríguez IP; García-Ortiz JE; Domínguez MG
    J Genet; 2019 Jun; 98(2):. PubMed ID: 31204697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.
    Palmer SJ; Santucci N; Widagdo J; Bontempo SJ; Taylor KM; Tay ES; Hook J; Lemckert F; Gunning PW; Hardeman EC
    J Biol Chem; 2010 Feb; 285(7):4715-24. PubMed ID: 20007321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-Seq analysis of Gtf2ird1 knockout epidermal tissue provides potential insights into molecular mechanisms underpinning Williams-Beuren syndrome.
    Corley SM; Canales CP; Carmona-Mora P; Mendoza-Reinosa V; Beverdam A; Hardeman EC; Wilkins MR; Palmer SJ
    BMC Genomics; 2016 Jun; 17():450. PubMed ID: 27295951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy is a possible feature in Williams-Beuren syndrome patients harboring typical deletions of the 7q11.23 critical region.
    Nicita F; Garone G; Spalice A; Savasta S; Striano P; Pantaleoni C; Spartà MV; Kluger G; Capovilla G; Pruna D; Freri E; D'Arrigo S; Verrotti A
    Am J Med Genet A; 2016 Jan; 170A(1):148-55. PubMed ID: 26437767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.
    Schneider T; Skitt Z; Liu Y; Deacon RM; Flint J; Karmiloff-Smith A; Rawlins JN; Tassabehji M
    Behav Brain Res; 2012 Aug; 233(2):458-73. PubMed ID: 22652393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical deletion of Williams-Beuren syndrome reveals the mechanism of neurodevelopmental disorders.
    Zhou J; Zheng Y; Liang G; Xu X; Liu J; Chen S; Ge T; Wen P; Zhang Y; Liu X; Zhuang J; Wu Y; Chen J
    BMC Med Genomics; 2022 Apr; 15(1):79. PubMed ID: 35379245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlation and the size of microdeletion or microduplication of 7q11.23 region in patients with Williams-Beuren syndrome.
    Ghaffari M; Tahmasebi Birgani M; Kariminejad R; Saberi A
    Ann Hum Genet; 2018 Nov; 82(6):469-476. PubMed ID: 30155880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
    Franke Y; Peoples RJ; Francke U
    Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
    Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
    Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.